PPT-Saving Our Elderly Patients From

Drug Adverse Effects Abdul Elahi MD MPH Assistant Professor of Medicine NJISA UMDNJSchool of Osteopathic Medicine Stratford NJ Saving our Elderly Patients from Drug Adverse Effects This . Anthony J. DiPasquale, D.O.. FACOEP. UMDNJ-SOM. Trauma & Falls in the Elderly Patient. This . Care of the Aging Medical Patient in the Emergency Room. . (CAMP. ER. ). presentation is offered by the Department of Emergency Medicine in coordination with the New Jersey Institute for Successful Aging.. Dr. Makena Mbogori- Medical Officer, Orthopaedic Surgery. . Dr. Michael Maru- Consultant Orthopaedic Surgeon. P.C.E.A. Kikuyu Hospital. OUTLINE. Introduction. Background. Aim . Objectives. Methodology. Giorgio V. Scagliotti. University. of . Torino,. . Department. . of . Oncology. giorgio.scagliotti@unito.it. Key. . points. of the . presentation. Incidence. Age . cut. -off. Comorbidity. & . Geriatric Patients. Disproportionately high prescription drug use exists in the elderly.. 12% of Americans are age 65 years or older.. This 12% consumes 31% of prescribed drugs.. Geriatric patients experience more adverse drug reactions and drug-drug interactions than younger patients do.. of . Age. . Hiromichi. Suzuki, Tsutomu . Inoue,Tomohiro. . Kikuta. , . Yusuke Watanabe, Hirokazu Okada.  . . Department of Nephrology, Saitama Medical University. Nephro-2014. COI. 　. Author. Why Anticoagulate?. Anticoagulate Even in High-Risk Patients ?. Efficacy and Safety of NOACs vs Warfarin in NVAF by Age. Efficacy and Safety of Edoxaban . vs Warfarin by Age in ENGAGE AF-TIMI 48. Efficacy and Safety of NOACs vs Warfarin in the ≥75 Age Group. Karen Birmingham, PharmD, BCPS. Specialty Clinical Pharmacy Services. Group Health. “Quote”worthy Definitions. Aging. “Progressive accumulation . of random changes”. “Time-related loss of. yo. Patient). A 88 . yo. man with hypertension, COPD, . atrial. fibrillation presents with severe CP and is diagnosed with a NSTEMI. He is found to have 90% LAD occlusion and receives a drug eluting stent. Current meds: . Authors -author James F Hanley III MDTitle You get what you pay for the failure to document Functional Status in Hospitalized Elderly PatientsIntroductionFunctional status and cognitive function are t Kevin Biese, MD, MAT. Ellen Roberts PhD, MPH. Jan . Busby-Whitehead, MD. University of North Carolina . at . Chapel Hill. Division of Geriatric Medicine. Center for Aging and Health . Department of Emergency Medicine. Sarah . M. . McGee, MD. , MPH. Director of Education . Division of Geriatrics. November 7, . 2008. August . 5, . 2009. THE AMERICAN GERIATRICS SOCIETY. Geriatrics Health Professionals.. Leading change. Improving care for older adults.. May 25, 2013. Mala Joneja, MD MEd FRCPC . Identify factors that contribute to risk in the medical treatment of Rheumatic Diseases in the elderly population. Identify risks associated with specific pharmacological interventions in the elderly. . Michael Shannon, . MD. Endocrinologist . and PSW Medical Director. - Fall Quality Summit Agenda - . Welcome!. . 6:00 – 6:30 Networking & Appetizers . 6:30 – 6:40 Dr. Gary Goin, MD . Introductions . 30.07.2020. “. Safety. . and. . feasibility. . of. transjugular . intrahepatic. . portosystemic. . shunt. in . elderly. . patients. . with. . liver. . cirrhosis. . and. . refractory. .